These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8723472)

  • 21. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
    Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
    Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of dapsone in human immunodeficiency virus-infected children.
    Gatti G; Loy A; Casazza R; Miletich F; Cruciani M; Bassetti D
    Antimicrob Agents Chemother; 1995 May; 39(5):1101-6. PubMed ID: 7625796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
    Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
    N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ; Hauptman SP
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
    El-Sadr WM; Murphy RL; Yurik TM; Luskin-Hawk R; Cheung TW; Balfour HH; Eng R; Hooton TM; Kerkering TM; Schutz M; van der Horst C; Hafner R
    N Engl J Med; 1998 Dec; 339(26):1889-95. PubMed ID: 9862944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Some aspects of the treatment of HIV infection].
    Costantino M
    Minerva Ginecol; 1991 Dec; 43(12):608-9. PubMed ID: 1840280
    [No Abstract]   [Full Text] [Related]  

  • 27. Zidovudine for treating AIDS. What physicians need to know.
    Amin NM
    Postgrad Med; 1989 Jul; 86(1):195-6, 201-8. PubMed ID: 2662155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus.
    Lertora JJ; Rege AB; Greenspan DL; Akula S; George WJ; Hyslop NE; Agrawal KC
    Clin Pharmacol Ther; 1994 Sep; 56(3):272-8. PubMed ID: 7924122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the in vivo effect of naproxen on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus.
    Sahai J; Gallicano K; Garber G; Pakuts A; Hawley-Foss N; Huang L; McGilveray I; Cameron DW
    Clin Pharmacol Ther; 1992 Nov; 52(5):464-70. PubMed ID: 1424420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic interaction of megestrol acetate with zidovudine in human immunodeficiency virus-infected patients.
    Van Harken DR; Pei JC; Wagner J; Pike IM
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2480-3. PubMed ID: 9371353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Bucher HC; Griffith L; Guyatt GH; Opravil M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):104-14. PubMed ID: 9241108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the medical management of early HIV disease.
    Volberding PA
    J Gen Intern Med; 1991; 6(1 Suppl):S7-12. PubMed ID: 2005480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Several aspects of the treatment of HIV infections].
    Costantino M
    Minerva Med; 1992; 83(1-2):81-2. PubMed ID: 1545928
    [No Abstract]   [Full Text] [Related]  

  • 34. Population pharmacokinetics of dapsone in children with human immunodeficiency virus infection.
    Mirochnick M; Cooper E; Capparelli E; McIntosh K; Lindsey J; Xu J; Jacobus D; Mofenson L; Bonagura VR; Nachman S; Yogev R; Sullivan JL; Spector SA
    Clin Pharmacol Ther; 2001 Jul; 70(1):24-32. PubMed ID: 11452241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pneumocystis carinii pneumonia: therapy and prophylaxis.
    Kovacs JA; Masur H
    J Infect Dis; 1988 Jul; 158(1):254-9. PubMed ID: 2969023
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia.
    Blum RN; Miller LA; Gaggini LC; Cohn DL
    J Acquir Immune Defic Syndr (1988); 1992; 5(4):341-7. PubMed ID: 1548570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse reactions to dapsone in persons infected with human immunodeficiency virus.
    Pertel P; Hirschtick R
    Clin Infect Dis; 1994 Apr; 18(4):630-2. PubMed ID: 8038322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
    Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
    N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population-based estimates of antiretroviral therapy and anti-Pneumocystis prophylaxis in San Francisco: 1991.
    Lang W; Osmond D; Page-Bodkin K; Moss A; Winkelstein W
    J Acquir Immune Defic Syndr (1988); 1993 Feb; 6(2):191-5. PubMed ID: 8381868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.
    Chien SC; Chow AT; Rogge MC; Williams RR; Hendrix CW
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1765-9. PubMed ID: 9257757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.